J. W. Almond, G. D. Westrop, D. M. Evans, G. Dunn, P. D. Minor et al., Studies on the attenuation of the Sabin type 3 oral polio vaccine, Journal of Virological Methods, vol.17, issue.1-2, pp.183-189, 1987.
DOI : 10.1016/0166-0934(87)90081-4

T. S. Beswick and C. R. Coid, The influence of technique on the sensitivity of monkeys to intraspinally inoculated poliovirus, Journal of Hygiene, vol.171, issue.04, pp.395-399, 1961.
DOI : 10.1002/path.1700760231

N. Cammack, A. Phillips, G. Dunn, V. Patel, and P. D. Minor, Intertypic genomic rearrangements of poliovirus strains in vaccinees, Virology, vol.167, issue.2, pp.507-514, 1988.
DOI : 10.1016/S0042-6822(88)90113-4

A. J. Cann, G. Stanway, P. J. Hughes, P. D. Minor, D. M. Evans et al., Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine, Nucleic Acids Res, vol.20, pp.7787-7792, 1984.

F. Colbere-garapin, C. Christodoulou, R. Crainic, A. C. Garapin, and A. Candrea, Addition of a foreign oligopeptide to the major capsid protein of poliovirus., Proc. Natl. Acad. Sci. USA, pp.8668-8672, 1988.
DOI : 10.1073/pnas.85.22.8668

R. Crainic, B. Blondel, A. Candrea, G. Dufraisse, and F. Horaud, Antigenic modifications of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures, Dev. Biol. Standard, vol.60, pp.343-347, 1985.

D. M. Evans, G. Dunn, P. D. Minor, G. C. Schild, A. J. Cann et al., Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome, Nature, vol.12, issue.6011, pp.548-550, 1985.
DOI : 10.1038/314548a0

T. D. Hey, E. Richards, and . Ehrenfeld, Synthesis of plus-and minus-strand RNA from poliovirion RNA template in vitro, J. Virol, vol.58, pp.790-796, 1986.

F. Horaud, R. Crainic, and B. Blondel, Polio vaccine: From empiricism and efficacyto scientific knowledge, Annales de l'Institut Pasteur / Virologie, vol.136, issue.4, pp.527-545, 1985.
DOI : 10.1016/S0769-2617(85)80144-1

N. Kawamura, M. Kohara, S. Abe, T. Komatsu, K. Tago et al., Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype, J. Virol, vol.63, pp.1302-1309, 1989.

0. M. Kew, B. K. Nottay, and N. Y. , Evolution of the oral polio vaccine strains in humans occurs by both mutation and intramolecular recombination Modern approaches to vaccines, pp.357-367, 1984.

A. J. Adler, E. A. Dorner, R. Emini, J. J. Hanecak, S. Lee et al., Primary structure, gene organization and polypeptide expression of poliovirus RNA, Nature, vol.291, pp.547-553, 1981.

M. Kohara, T. Omata, A. Kameda, B. L. Semler, H. Itoh et al., In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain, J. Virol, vol.53, pp.786-792, 1985.

S. Kuge, N. Kawamura, and A. Nomoto, Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1, J. Virol, vol.63, pp.1069-1075, 1989.

U. K. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1038/227680a0

L. Monica, N. , C. Meram, and V. Racaniello, Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing, J. Virol, vol.57, pp.515-525, 1986.

L. Monica, N. , and V. R. Racaniello, Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SYSY, J. Virol, vol.63, pp.2357-2360, 1989.

A. Lwoff, Factors influencing the evolution of viral diseases at the cellular level and in the organism, Bacteriol. Rev, vol.23, pp.109-124, 1959.

A. Lwoff, Death and transfiguration of a problem, Bacteriol . Rev, vol.33, pp.390-403, 1969.

A. Lwoff and M. Lwoff, L'inhibition du ddveloppement du virus poliomydlitique A 390 et le probleme du r6le de l'hyperthermie dans l'evolution des infections virales, C. R, 1958.

A. Martin, C. Wychowski, T. Couderc, R. Crainic, J. Hogle et al., Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice, EMBO J, vol.7, pp.2839-2847, 1988.

P. D. Minor, G. Dunn, D. M. Evans, D. I. Magrath, A. John et al., The Temperature Sensitivity of the Sabin Type 3 Vaccine Strain of Poliovirus: Molecular and Structural Effects of a Mutation in the Capsid Protein VP3, Journal of General Virology, vol.70, issue.5, pp.1117-1123, 1989.
DOI : 10.1099/0022-1317-70-5-1117

M. G. Murray, J. Bradley, X. F. Yang, E. Wimmer, E. G. Moss et al., Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I, Science, vol.241, issue.4862, pp.213-214, 1988.
DOI : 10.1126/science.2838906

J. H. Nakano, M. H. Hatch, W. Thieme, and B. Nottay, Parameters for differentiating vaccine-derived and wild poliovirus strains, Prog. Med. Virol, vol.24, pp.178-206, 1978.

M. S. Oberste and J. B. Flanegan, Measurement of poliovirus RNA polymerase binding to poliovirion and nonviral RNAs using a filter-binding assay, Nucleic Acids Research, vol.16, issue.21, pp.10339-10352, 1988.
DOI : 10.1093/nar/16.21.10339

. Nomoto, Genetic analysis of the attenuation phenotype of poliovirus type 1, J. Virol, vol.58, pp.348-358, 1986.

. Palese, Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1, J. Virol, vol.59, pp.377-383, 1986.

J. Pelletier and N. Sonenberg, Internal binding of eucaryotic ribosomes on poliovirus RNA: translation in HeLa cell extracts, J. Virol, vol.63, pp.441-444, 1989.

E. V. Pilipenko, V. M. Blinov, L. I. Romanova, A. N. Sinyakov, S. V. Maslova et al., Conserved structural domains in the 5???-untranslated region of picornaviral genomes: An analysis of the segment controlling translation and neurovirulence, Virology, vol.168, issue.2, pp.201-209, 1989.
DOI : 10.1016/0042-6822(89)90259-6

V. R. Racaniello, Viral sequences required for neurovirulence of poliovirus, BioEssays, vol.50, issue.6, pp.217-246, 1987.
DOI : 10.1002/bies.950050608

V. R. Racaniello, Poliovirus Neurovirulence, Adv. Virus Res, vol.34, pp.217-246, 1988.
DOI : 10.1016/S0065-3527(08)60519-9

V. R. Racaniello and D. Baltimore, Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome., Proc. Natl. Acad. Sci. USA, pp.4887-4891, 1981.
DOI : 10.1073/pnas.78.8.4887

A. B. Sabin and L. R. Boulger, History of Sabin attenuated poliovirus oral live vaccine strains, Journal of Biological Standardization, vol.1, issue.2, pp.115-118, 1973.
DOI : 10.1016/0092-1157(73)90048-6

A. B. Sabin and A. Lwoff, Relation between reproductive capacity of polioviruses at different temperatures in tissue culture and neurovirulence, Science, vol.129, pp.1287-1288, 1958.

J. E. Salk, Consideration in the preparation and use of poliomyelitis virus vaccine, J. Am. Med. Assoc, vol.1548, pp.1239-1248, 1955.

F. Sanger, S. Nicklen, and A. R. Coulson, DNA sequencing with chain-terminating inhibitors, Proc. Natl. Acad. Sci. USA, pp.5463-5467, 1977.
DOI : 10.1073/pnas.74.12.5463
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC431765

P. Sarnow, Role of 3'-end sequences in infectivity of poliovirus transcripts made in vitro, J. Virol, vol.63, pp.467-470, 1989.

P. Sarnow, H. D. Bernstein, and D. Baltimore, A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome., Proc. Natl. Acad. Sci. USA, pp.571-575, 1986.
DOI : 10.1073/pnas.83.3.571

M. A. Skinner, V. R. Racaniello, G. Dunn, J. Cooper, P. D. Minor et al., New model for the secondary structure of the 5??? non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence, Journal of Molecular Biology, vol.207, issue.2, pp.379-392, 1989.
DOI : 10.1016/0022-2836(89)90261-1

G. Stanway, P. J. Hughes, R. C. Mountford, P. Reeve, P. D. Minor et al., Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b., Proc. Natl. Acad. Sci. USA, pp.1539-1543, 1984.
DOI : 10.1073/pnas.81.5.1539

H. Toyoda, M. Kohara, Y. Kataoka, T. Suganuma, T. Omata et al., Complete nucleotide sequences of all three poliovirus serotype genomes, Journal of Molecular Biology, vol.174, issue.4, pp.561-585, 1984.
DOI : 10.1016/0022-2836(84)90084-6

H. Toyoda, C. Yang, N. Takeda, A. Nomoto, and E. Wimmer, Analysis of type 1 poliovirus by using an in vitro molecular genetic approach, J. Virol, vol.61, pp.2816-2822, 1987.

G. C. Skinner, J. W. Schild, and . Almond, Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine, J. Virol, vol.63, pp.1338-1344, 1989.

K. J. Wiegers and R. Dernick, Poliovirus-specific Polypeptides in Infected HeLa Cells Analysed by Isoelectric Focusing and 2D-Analysis, Journal of General Virology, vol.52, issue.1, pp.61-69, 1981.
DOI : 10.1099/0022-1317-52-1-61

D. Zimmern and P. Kaesberg, 3'-terminal nucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors., Proc. Natl. Acad. Sci. USA, pp.4257-4261, 1978.
DOI : 10.1073/pnas.75.9.4257